Table II.
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Characteristics | HR | 95% CI | P-value | HR | 95% CI | P-value |
Age | ||||||
≤40 years | 1 | |||||
>40 years | 0.765 | 0.387–1.510 | 0.439 | |||
Tumor size | ||||||
≤2 cm | 1 | 1 | ||||
>2 cm | 2.280 | 1.121–4.635 | 0.023 | 1.077 | 0.507–2.288 | 0.847 |
Histopathological grade | ||||||
I | 1 | |||||
II | 1.019 | 0.462–2.244 | 0.964 | |||
III | 1.102 | 0.726–1.674 | 0.648 | |||
ER | ||||||
− | 1 | 1 | ||||
+ | 0.444 | 0.231–0.854 | 0.015 | 0.415 | 0.212–0.812 | 0.010 |
PR | ||||||
− | 1 | |||||
+ | 0.703 | 0.356–1.387 | 0.309 | |||
HER2 | ||||||
− | 1 | |||||
+ | 1.087 | 0.560–2.108 | 0.805 | |||
Lymph node status | ||||||
− | 1 | 1 | ||||
+ | 4.984 | 2.561–9.700 | <0.01 | 5.262 | 2.590–10.691 | <0.001 |
SHOC2 expression | ||||||
Low | 1 | |||||
High | 3.428 | 1.212–9.697 | 0.020 | 5.440 | 1.865–15.863 | <0.001 |
ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor; SHOC2, SHOC2 leucine rich repeat scaffold protein.